AbbVie Slaps Mankind Away Until 2027 On US Lumigan Generic
ANDA Sponsor And Originator Agree To Jointly Dismiss Patent Infringement Proceedings
The wait for US competition to AbbVie’s Lumigan 0.01% glaucoma brand, launched more than a decade ago, goes on, after Mankind bowed to infringement of a key US patent.
